Zdrowie i gospodarka · 30/10/2006

FDA Requests Public Comment on Proposed Collection of Information for Orphan Drugs

The Food and Drug Administration (FDA) is seeking public input on a proposed rule that outlines procedures for orphan drug sponsors to request incentives under the Orphan Drug Act, as required by the Paperwork Reduction Act of 1995.